7.12.2021 21:27:37 CET | Aqua Bio Technology ASA | Non-regulatory press releases

Cosmed (Norway) is the first distributor to launch Moana Skincare broadly in
Norway and has a distribution model that covers about approx. 900 stores. Cosmed
- https://www.cosmedbeautyshop.no/merker/moana-skincare is actively using Moana
Skincare seminars, Instagram, Facebook and influencers in its commercialization
process and has established a new physical Cosmed store at Lillestrøm Torv -
https://lillestromtorv.no/ for their skincare products. ABT received the first
order from Cosmed in August 2021. Cosmed will also commence distribution of B
Natural in Norway.

Sitil Bohemia (Prague) is distributing Moana Skincare, Seidr and Seidr Clinique
in the Czech Republic and Slovakia via the online shop Klidnesiuzivam -
https://www.klidnesiuzivam.cz/ supported by inhouse social media team on
Facebook and Instagram. ABT has received the first orders for both Moana
Skincare, Seidr and Seidr Clinique.

Maikiwi Ltd (Auckland) is distributing Moana Skincare in Mainland China -
https://live.euronext.com/node/6349532 and ABT received the first order on Moana
Skincare in September 2021 since the new distribution agreement was entered into
in August 2021. 

D & S Maisey Limited (Auckland and Manila) has a letter of intent for the
exclusive distribution of Moana Skincare in Japan and the Philippines. The
registration documents for Japan are under review, and preparation for launch is
ongoing - https://www.dsmaisey.com/.

Al-Dawaa Pharmacies (Saudi Arabia) has started the registration process of Moana
Skincare in Saudi Arabia and contemplates an initial launch of Moana Skincare to

50 pharmacies - https://live.euronext.com/node/4731849 across Saudi Arabia. The
registration process is delayed due to an organizational change in Al-Dawaa, so
the launch is expected to take place in 2022. 

DNO Group International Trading -
https://www.globenewswire.com/news-release/2019/06/14/1869004/0/en/ABT-announces
-distribution-agreement-for-India-and-Hong-Kong.html (Hong Kong) is currently
evaluating Moana Skincare. DNO Group International Trading markets and
distributes third party beauty products in seven Asian markets that all are
enjoying rapid growth.

DBK Pharmaceuticals S.A.E. - https://live.euronext.com/node/4226370 (Egypt) is a
fast-growing company engaged in the marketing and sales of high-end cosmetics as
well as other consumer goods in Egypt. There is a delay in the registration
process, but subject to completion of the registration process, ABT has received
its first order on Moana Skincare.

Moana Active Skincare Ltd - https://live.euronext.com/node/4095427 (New Zealand)
is one of the three producers of the Moana Skincare Brand and has a distribution
agreement for New Zealand and Australia, retaining ABT's local presence and
knowledge of Moana Skincare Brand origin. Moana Active Skincare Ltd. will
participate in and facilitate a contemplated rebranding of the Moana Skincare
Brand. ABT has received its first order on Moana Skincare.

Launch of Seidr, Seidr Clinique and B Natural

Covid 19-issues delayed the production (lock-down) and delivery of products
(logistics) following this Summer's launch, but ABT has received good attention
in the market and expects to enter into new distribution agreement in Europe for
these brands. Sitil Bohemia is the first Seidr and Seidr Clinique distributor in
Europe and Cosmed are ready for B Natural distribution in Norway. 

Production & Logistics

ABT has previously entered into a manufacturing agreement with the newly
incorporated Moana Active Skincare Ltd for the production of Moana Skincare. 
This company - https://live.euronext.com/node/4095427 will also distribute Moana
Skincare in New Zealand and Australia. To secure timely production and supply of
Moana Skincare and B Natural, Pauling Industries - https://www.pauling.co.nz/ in
New Zealand and DCP Dermoscience - https://www.dcpdermoscience.com/en/ in Canada
will also produce Moana Skincare and B Natural for ABT in the future.

Atyp - Advertising and Media Agency

ABT will hire ATYP to increase ABTs skincare product visibility and recognition
in the market. Atyp - https://atyp.no/ is a recognized full-service hybrid
agency that aims to develop creative solutions for market share growth and brand
recognition through seamlessly integrating brand strategy, creativity, design,
media performance and technology.

Restorsea LLC

Restorsea was in 2012 given exclusive and global sub-licensing rights to
AquabeautineXL?, ABT's proprietary technology until 2032. Restorsea sells its
own products series based on AquabeautineXL? through its own website,
Amazone.com, appr. 134 physician clinics in the USA, as well as through clinics
and websites in Brazil. In 2021 Restorsea announced licensing agreements with
Nasdaq-listed LifeMD and Nasdaq-listed Hydrafacial. Hydrafacial launched key
products based on AquabeautineXL? in February 2021 and LifeMD expects to launch
a NAVA MD products based on ABT's proprietary technology in 2022.

In November 2021 Restorsea's launched several products from its PRO-line in
South Korea. South Korea is one of the top 10 beauty markets in the world,
representing nearly 2.8 percent of the global market and it is known that it is
a long process to have cosmetic products successfully registered in South Korea.
The products are distributed online through Shilla IPARK Duty Free Shop, the
world's largest downtown duty-free store.

ABT's exclusive supply and license agreement with Restorsea has so far provided
income of more than USD 21 M to ABT. Restorsea's supply and license agreement
are subject to Restorsea exercising its options to extend its exclusivity from
2022 to 2027, where the payments for continued exclusivity are due in 2022 (USD
2.5M) and 2027 (USD 2.5M). ABT receives royalties on sale of AquabeautineXL?,
end products and licensing fees from sub-license agreements.

ABT's income from royalties and sale of AquabeautineXL? increased in 2021 and
the positive trend from Restorsea's commercialization increases the likelihood
that ABT will receive additional renewal payments (USD 2.5M in 2022) and
increased revenue from the sale of ingredients and royalties.

R&D Project related to production of Aquabeautine XL

ABT expects to complete the first step of its R&D project related to the
production of
Aquabeautine XL during first half of 2022. Besides facilitating a larger
automation of the production process, ABT also hope to further increase the
sustainability of its key ingredient based on its proprietary technology

***

For further information, please contact CEO Håvard Lindstrøm mobile phone +47
941 32 288.

Aqua Bio Technology is developing and commercializing sustainable biotechnology
for use in skincare products. ABT's cosmetics ingredients are highly effective
and they provide the cosmetics industry with natural alternatives to traditional
ingredients. ABT is also marketing and distributing natural skincare products
developed by partners towards consumers and professional users. ABT's focus on
commercialization and development of natural ingredients and natural skincare
products has been, and will continue to be, an important part of the Company's
strategy going forward. Aqua Bio Technology is listed on the Euronext Expand
market of the Oslo Stock Exchange.

 

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

 * Håvard Lindstrøm, 004794132288, hl@aquabiotech.no 

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/1045/1400/Download%20announcement
%20as%20PDF.pdf